To include your compound in the COVID-19 Resource Center, submit it here.

Less to gain

Why biotech stocks missed out on the tax reform rally in 4Q17

While most of the stock market partied in 4Q17 as the tax reform bill approached the goal line, biotech stocks have sulked in the corner.

Republicans turned their full attention to tax reform in late September and after a flurry of

Read the full 401 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers